59376-79-3

Usage

Uses

Used in Pharmaceutical and Agrochemical Industries:
5,7-DIMETHYL-1,2,3,4-TETRAHYDRO-NAPHTHALEN-1-YLAMINE is used as a building block in the synthesis of various pharmaceutical and agrochemical products. Its unique chemical structure allows it to be a valuable component in the development of new drugs and agrochemicals, enhancing their efficacy and performance.
Used in Organic Electronic Materials:
5,7-DIMETHYL-1,2,3,4-TETRAHYDRO-NAPHTHALEN-1-YLAMINE has been studied for its potential use in organic electronic materials. Its properties make it a promising candidate for applications in organic electronics, such as organic light-emitting diodes (OLEDs), organic photovoltaics (OPVs), and organic field-effect transistors (OFETs), where it can contribute to improved device performance and stability.
Used as a Ligand in Coordination Chemistry:
In coordination chemistry, 5,7-DIMETHYL-1,2,3,4-TETRAHYDRO-NAPHTHALEN-1-YLAMINE is used as a ligand. Its ability to form stable complexes with various metal ions makes it a useful component in the design and synthesis of coordination compounds with potential applications in catalysis, sensing, and other areas of chemistry.

Upstream product

• 13621-25-5 5,7-dimethyltetralone 
• 90400-79-6 5,7-dimethyl-3,4-dihydronaphthalen-1(2H)-one oxime 

Relevant academic research and scientific papers

ION CHANNEL INHIBITOR COMPOUNDS FOR CANCER TREATMENT

The present invention concerns a compound of following general formula (I): where: either R is an R1 group and R′ is an -A1-Cy1 group, or R is an -A1-Cy1 group and R′ is an R1 group, R1 particularly being H or (C1-C6)alkyl group;A1 being an —NH— radical or —NH—CH2— radical;Cy1 particularly being a phenyl group,A is a fused (hetero)aromatic ring having 5 to 7 atoms, for use for treating cancer.

THERAPEUTIC COMPOUNDS

Disclosed herein is a compound having a structure (I), compositions, methods, and medicaments related thereto are also disclosed.

HETEROCYCLYL SUBSTITUTED FUSED CARBOCYLES USEFUL IN THE TREATMENT OF CONDITIONS SUCH AS GLAUCOMA AND PAIN

Disclosed herein is a compound having a structure (I), compositions, methods, and medicaments related thereto are also disclosed.

SUBSTITUTED FLUOROETHYL UREAS AS ALPHA 2 ADRENERGIC AGENTS

Therapeutic compounds, and methods, compositions, and medicaments related thereto are disclosed herein.

NOVEL 2-AMINO BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS MODULATORS OF SMALL-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS

This invention relates to novel 2-amino benzimidazole derivatives useful as modulators of small-conductance calcium-activated potassium channels (SK channels). In other aspects the invention relates to the use of these compounds in a method for therapy an

Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof

The present invention relates to the discovery that certain non-naturally occurring, non-peptide amide compounds and amide derivatives, such as oxalamides, ureas, and acrylamides, are useful flavor or taste modifiers, such as a flavoring or flavoring agents and flavor or taste enhancer, more particularly, savory (the “umami” taste of monosodium glutamate) or sweet taste modifiers,—savory or sweet flavoring agents and savory or sweet flavor enhancers, for food, beverages, and other comestible or orally administered medicinal products or compositions.